Tadalafil NOBEL 20 mg, Filmtabletten - 4 Swissmedic Key 69811006 Registration Holder NOBEL Pharma Schweiz AG Name Tadalafil NOBEL 20 mg, Filmtabletten Date of registration 29.07.2025 Introduction of Sequence 29.07.2025 ATC-Classification Tadalafil (G04BE08) Revision date WHO WHO-DDD Valid until 28.07.2030 Index Therapeuticus (BSV) Show package size 4 Index Therapeuticus (Swissmedic) 05.99. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680698110064 Medication Code Synthetika Pharmacode Disponibility
Composition tadalafilum 20 mg, lactosum 312.5 mg, carmellosum natricum conexum, natrii laurilsulfas, hydroxypropylcellulosum, polysorbatum 80, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 2.8 mg, triacetinum, talcum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 1.91 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Tadalafilum 20 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum E 171 color. E 172 color. Hydroxypropylcellulosum Hypromellosum Überzug Lactosum 312.5 mg Lactose Monohydrate 2.8 mg Magnesii Stearas Natrii Laurilsulfas Polysorbatum 80 Pro Compresso Obducto Talcum Triacetinum
Source Data was imported : 07.08.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
